Does Rallies show 13F holders for HOLX?

Yes. Rallies tracks hedge fund and 13F ownership data for HOLX, including fund names, share counts, latest tracked quarter, and position changes when available.

Is HOLX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for HOLX. It does not provide personalized investment advice.

HOLX (Hologic) Stock Analysis - Hedge Fund Holdings

Hologic (HOLX) is a publicly traded Healthcare sector company. As of May 20, 2026, HOLX trades at $76.01 with a market cap of $16.97B and a P/E ratio of 31.41. HOLX moved +0.00% today. Year to date, HOLX is +2.52%; over the trailing twelve months it is +23.21%. Its 52-week range spans $51.90 to $84.39. Analyst consensus is hold with an average price target of $79.00. Rallies surfaces HOLX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns HOLX stock?

Hedge funds tracked by Rallies that own HOLX include Pentwater Capital, Davidson Kempner, Soros Fund, Centerbook Partners, and Bridgewater Associates. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Hologic.

HOLX Key Metrics

Key financial metrics for HOLX
Metric	Value
Price	$76.01
Market Cap	$16.97B
P/E Ratio	31.41
EPS	$2.42
Dividend Yield	0.00%
52-Week High	$84.39
52-Week Low	$51.90
Volume	102.03M
Avg Volume	0
Revenue (TTM)	$4.13B
Net Income	$543.80M
Gross Margin	51.47%

Top Hedge Funds Holding HOLX

Pentwater Capital holds 4.50M shares of HOLX, changed +5.95% as of Mar 31, 2026.
Davidson Kempner holds 1.62M shares of HOLX, changed +124.75% as of Mar 31, 2026.
Soros Fund holds 1.01M shares of HOLX, changed +15.65% as of Mar 31, 2026.
Centerbook Partners holds 57.32K shares of HOLX, changed +0.00% as of Mar 31, 2026.
Bridgewater Associates holds 11.30K shares of HOLX, changed -15.95% as of Mar 31, 2026.

Latest HOLX News

Hologic Q1 Diagnostics Revenue Dips 1.3% to $464.4M as Molecular Sales Drop — Mar 6, 2026
Lumos Diagnostics posts $6.12M H1 sales, lands $317M US FebriDx deal — Feb 27, 2026
Blackstone, TPG Offer $18.3B for Hologic at 46% Premium — Feb 26, 2026
Hologic’s $18.3B Buyout Nears Close After 99.8% Vote, China OKs Acquisition — Feb 16, 2026
Hologic Q1 EPS Misses by $0.05, Gross Margin Falls 150 Bps — Jan 30, 2026

HOLX Analyst Consensus

42 analysts cover HOLX: 0 strong buy, 18 buy, 23 hold, 1 sell, 0 strong sell. Consensus rating is hold. Average price target: $79.00.

Common questions about HOLX

Who owns HOLX stock?: Hedge funds tracked by Rallies that own HOLX include Pentwater Capital, Davidson Kempner, Soros Fund, Centerbook Partners, and Bridgewater Associates. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Hologic.
Does Rallies show 13F holders for HOLX?: Yes. Rallies tracks hedge fund and 13F ownership data for HOLX, including fund names, share counts, latest tracked quarter, and position changes when available.
Is HOLX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for HOLX. It does not provide personalized investment advice.